Posted by Drug carriers are special tools used for the transportation and preservation of molecules for several pharmaceutical, cosmetic and nutraceutical applications.
Nanoparticles are spherical objects, generally employed in pharmaceutical applications, such as gene therapy, the delivery of proteins, dietary supplements, vitamin, antibiotics and vaccines. Nanotubes are hollow cylinders of carbon, used to treat carcinogenic cells or tissues. Dendrimers are more complex arrays of carriers, with a branched shape used for the simultaneous and efficient transportation of drugs. Liposomes are spherical vesicles composed of an inner aqueous core surrounded by a double layer of phospholipids, particularly useful since they are biocompatible with human cells. Polymersomes are spherical vesicles obtained with a polymer coating, which guarantees a controlled and delayed drug release. Instead, niosomes are spherical vesicles composed of nonionic surfactant active agents.
In this Special Issue, the presentation of novel methodologies for the production of drug carriers, as well as new potential findings regarding the physics of the problem are welcome. Moreover, the innovation of products provided by conventional methods as well as innovative processes and on products are also going to be taken under great consideration. Finally, the economic analysis of the process of productive plants is also an aim of this Special Issue, as well as the processes’ environmental impact.
The Special Issue “Drug Carriers Production Processes for Innovative Human Applications” (https://www.mdpi.com/journal/processes/special_issues/Drug_Carriers_Human_Applications ) in the Open Access Journal Processes (ISSN 2227-9717; indexed in *SCIE* and *Scopus*; IF = 3.352 and Citescore = 3.5) is edited by
–.Prof. Paolo Trucillo
University of Naples Federico II
- Early-bird submission before 30 April 2023: 30% discount.
** Early-bird submission before 15 June 2023: 20% discount.
read more: https://www.mdpi.com/journal/processes/special_issues/Drug_Carriers_Human_Applications